Please login to the form below

Not currently logged in
Email:
Password:

Vertex Pharmaceuticals

This page shows the latest Vertex Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO

Reshma Kewalramani joins Vertex Pharmaceuticals as CMO. She will succeed Jeffrey Chodakewitz. ... Vertex Pharmaceuticals, a biotech known for its clinical development programmes in cystic fibrosis, has appointed a new chief medical officer in the form of

Latest news

More from news
Approximately 3 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • The good, the bad and the ugly The good, the bad and the ugly

    The biggest movers in respiratory were Teva (26%) and Vertex Pharmaceuticals (23.7%). ... Vertex has two - with Kalydeco sitting alongside Orkambi in an impressive respiratory portfolio.”.

  • Deal Watch March 2017 Deal Watch March 2017

    Vertex paid $160m in cash to Concert Pharmaceuticals to purchase the assets of CTP-656, and could pay an additional $90m in milestones based on regulatory approval and reimbursement. ... 250. Concert Pharmaceuticals. Vertex Pharmaceuticals. Product

  • Using social data to see patients more clearly Using social data to see patients more clearly

    This kind of information would have thrilled executives at Vertex Pharmaceuticals, the makers of Orkambi - and worried their competitors.

  • Deal Watch October 2015 Deal Watch October 2015

    17, 200. CRISPR Therapeutics/ Vertex Pharmaceuticals. CRISPR-Cas9 gene editing technology for discovery of new treatments for genetic diseases incl sickle cell disease, CF. ... Collaboration, option to license. 339. Regeneron Pharmaceuticals/ Mitsubishi

  • Orphan indication? No easy access Orphan indication? No easy access

    a series of incentives (including protocol assistance, extended market exclusivity, changes to the fee structure for registration) for the development of pharmaceuticals with orphan designation. ... found. Governments also step in in some instances, for

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics